Precision Business Insights
Portfolio

 

Generic Injectables Market

: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019 to 2023

Global Generic Injectables Market: By Molecule Type (Large & Small Molecule), By Drug Type (Monoclonal Antibodies, Peptide Hormones, Immunoglobulin, Cytokines, Blood Factors, Peptide Antibiotics, Insulin, Vaccines, and Others), By Indication (Cancer, Diabetes, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, Ophthalmic, and Others), By Route of Administration (Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), and Others), By Manufacturing Type (In-House and Outsource), By Distribution Channel (Hospital, Online, and Retail Pharmacies), By Presentation Type (Ampules, Vials, Prefilled Syringes, Lyophilized Products, Dry Powder Injectable, and Pen Injectors), and By End User (Human and Veterinary) and Geography

 

Global Generic Injectables Market

 

Global Generic Injectables Market Report Description:

Global generic injectables market report gives comprehensive outlook on generic injectables across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global generic injectables market gives historical, current, and future market sizes (US$ 90.2 Bn) on the basis of molecule type, drug type, by indication, by route of administration, by manufacturing, by distribution channel, by presentation, by end user, and region. This report studies global generic injectables market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global generic injectables market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global generic injectables market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global Generic Injectables market report include suppliers, manufacturers, marketers, and policy makers engaged in global generic injectables products.

 

Global Generic Injectables Market:

The global generic injectables market is expected to grow at US$ 90.2 Bn by 2023. Generic Injectables are gaining traction over the forecast period owing to their cost effectiveness and same efficacy as the branded drugs. Growing pressure on the drug prices by the various governments is forcing hospitals to prescribe generic injectables. Furthermore, supply continuity challenges are also driving the growth of generic injectables market. Moreover, increase in research and development for making the complex molecule suitable for injectable dosage forms, technological advancements, and increase in adoption of biosimilar products are also surging the growth of global generic injectables market.

 

Lower Costs of the Products Enhances Global Generic Injectables Market Growth

Lower costs of the generic drugs over the branded drugs streams the growth of global generic injectables market. For instance, the Indian government launched a scheme named Pradhan Mantri Jan Aushadhi Yojana to support the establishment of generic medical stores and to provide medicines at affordable price in rural areas.

 

Asia Pacific Accounts for Larger Market Revenue Share in Global Generic Injectables Market

According to regional analysis, Asia Pacific dominated the global generic injectables market through 2013-2018 and expected to dominate over 2019-2023 owing to increasing prevalence of several diseases such as cancer, diabetes, cardiovascular diseases, and musculoskeletal diseases etc. and higher consumption of generic drugs over the branded drugs sue to the cost effeteness of the generic drugs. After Asia Pacific, North America seems to dominate the global generic injectables market loss of patients of blockbuster drugs and due to approval of abbreviated new drug application (ANDA) drugs. Europe generic injectable market is also growing at a considerable rate due to their government initiatives to reduce the health care cost by supporting generic medicines.

 

Competition Assessment

Key player’s profiles in the global generic injectables market include:

  • Novartis
  • AbbVie Inc.
  • Amgen, Inc.
  • AstraZeneca Plc
  • Baxter International Inc.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novo Nordisk
  • Pfizer Inc
  • Hoffmann-La Roche Ltd
  • Sanofi SA

 

Global generic injectables market is surging owing to frequent acquisitions, product launch, and collaborations by the market players. For instance, in 2015, Merck announced that the European Commission (EC) approved KEYTRUDA (pembrolizumab), for the treatment of advanced (unresectable or metastatic) melanoma in adults.

 

In December 2017, Novartis had more than 200 projects in its clinical pipeline and over 500 clinical trials in progress and it invested US$ 8,319 Mn for its research and development activities.

 

Furthermore, in February 2018, Novartis acquired Advanced Accelerator Applications S.A. (AAA), a publicly listed radiopharmaceutical company that develops, manufactures and commercializes molecular nuclear medicines including Lutathera, a first-in-class radioligand therapy for neuroendocrine tumors.

 

Key Findings of the Report:

 

  • Global generic injectables market expanding at significant CAGR over 2019 to 2023 owing to launch of newer tests into market.
  • Based on molecule type, large molecule segment accounted for larger market revenue share in 2018 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in Global Generic Injectables Market

 

Detailed Segmentation

 

By Molecule Type

  • Large Molecule
  • Small Molecule

 

By Drug Type

  • Monoclonal Antibodies
  • Peptide Hormones
  • Immunoglobulin
  • Cytokines
  • Blood Factors
  • Peptide Antibiotics
  • Insulin
  • Vaccines
  • Others

                                 

By Indication

  • Cancer
  • Diabetes
  • Cardiovascular Diseases
  • Musculoskeletal
  • CNS
  • Infections
  • Ophthalmic
  • Others

 

By Route of Administration

  • Intravenous (IV)
  • Intramuscular (IM)
  • Subcutaneous (SC)
  • Others

 

By Manufacturing Type

  • In-House
  • Outsource

 

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

By Presentation Type

  • Ampules
  • Vials
  • Prefilled Syringes
  • Lyophilized Products
  • Dry Powder Injectable
  • Pen Injectors

 

By End User

  • Human
  • Veterinary

 

Geography

 

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

 

Key Features of the Report:

 

  • The report provides granular level information about the market size, regional market share, historic market (2013-2018) and forecast (2019-2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Table of Content

  1. Executive Summary
  2. Global Generic Injectables Market Introduction
    • Global Generic Injectables Market – Taxonomy
    • Global Generic Injectables Market –Definitions
      • By MoleculeType
      • By Drug Type
      • By Indication
      • By Route of Administration
      • By Manufacturing Type
      • By Distribution Channel
      • By Presentation Type
      • By End User
  1. Global Generic Injectables Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Generic Injectables Market Dynamic Factors – Impact Analysis
    • Global Generic Injectables Market – Competition Landscape
  2. Global Generic Injectables Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023
    • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Generic Injectables Market, By Molecule Type, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
    • Large Molecule
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Small Molecule
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Generic Injectables Market, By Drug Type, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
    • Monoclonal Antibodies
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Peptide harmones
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Imunoglobulin
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cytokines
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Blood Factors
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Peptide harmones
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Insulin
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Vaccines
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Generic Injectables Market, By Indication, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
    • Cancer
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diabetes
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cardiovascular Diseases
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Musculoskeletal
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • CNS
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Infections
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Opthalmic
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Infections
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Generic Injectables Market, By Route of Administration, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
    • Intravenous (IV)
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Intramuscular (IM)
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Subcutaneous (SC)
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Generic Injectables Market, By Manufacturing Type, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
    • In-House
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Outsource
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Generic Injectables Market, By Distribution Channel, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
    • Hospital Pharmacies
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Generic Injectables Market, By Presentation Type, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
    • Ampules
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Vials
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Prefilled Syringes
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Lyophilized Products
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Dry Powder Injectables
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Pen Injections
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Generic Injectables Market, By End User, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
    • Human
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Veterinary
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Generic Injectables Market Forecast, By Region, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Generic Injectables Market – Opportunity Analysis Index, By Molecule Type, Drug Type, By Indication, By Route of Administration, Manufacturing Type, By Distribution Channel, By Presentation Type, By End User, and Region, 2019 – 2023
  2. North America Generic Injectables Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
    • Molecule Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Large Molecule
      • Small Molecule
    • Drug Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Monoclonal Antibodies
      • Peptide Hormones
      • Immunoglobulin
      • Cytokines
      • Blood Factors
      • Peptide Antibiotics
      • Insulin
      • Vaccines
      • Others
    • By Indication Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Cancer
      • Diabetes
      • Cardiovascular Diseases
      • Musculoskeletal
      • CNS
      • Infections
      • Ophthalmic
      • Others
    • By Route of Administration Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Intravenous (IV)
      • Intramuscular (IM)
      • Subcutaneous (SC)
      • Others
    • By Manufacturing Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • In-House
      • Outsource
    • By Distribution Channel Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Presentation Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Ampules
      • Vials
      • Prefilled Syringes
      • Lyophilized Products
      • Dry Powder Injectable
      • Pen Injectors
    • By End User Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Human
      • Veterinary
    • Country Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US.
      • Canada
    • North America Generic Injectables Market – Opportunity Analysis Index, By Molecule Type, Drug Type, By Indication, By Route of Administration, Manufacturing Type, By Distribution Channel, By Presentation Type, By End User, and Country, 2019 – 2023
    • North America Generic Injectables Market Dynamics – Trends
  3. Europe Generic Injectables Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
    • Molecule Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Large Molecule
      • Small Molecule
    • Drug Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Monoclonal Antibodies
      • Peptide Hormones
      • Immunoglobulin
      • Cytokines
      • Blood Factors
      • Peptide Antibiotics
      • Insulin
      • Vaccines
      • Others
    • By Indication Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Cancer
      • Diabetes
      • Cardiovascular Diseases
      • Musculoskeletal
      • CNS
      • Infections
      • Ophthalmic
      • Others
    • By Route of Administration Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Intravenous (IV)
      • Intramuscular (IM)
      • Subcutaneous (SC)
      • Others
    • By Manufacturing Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • In-House
      • Outsource
    • By Distribution Channel Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Presentation Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Ampules
      • Vials
      • Prefilled Syringes
      • Lyophilized Products
      • Dry Powder Injectable
      • Pen Injectors
    • By End User Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Human
      • Veterinary
    • Country Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Generic Injectables Market – By Molecule Type, Drug Type, By Indication, By Route of Administration, Manufacturing Type, By Distribution Channel, By Presentation Type, By End User, and Country, 2019 – 2023
    • Europe Generic Injectables Market Dynamics – Trends
  4. Asia-Pacific Generic Injectables Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
    • Molecule Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Large Molecule
      • Small Molecule
    • Drug Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Monoclonal Antibodies
      • Peptide Hormones
      • Immunoglobulin
      • Cytokines
      • Blood Factors
      • Peptide Antibiotics
      • Insulin
      • Vaccines
      • Others
    • By Indication Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Cancer
      • Diabetes
      • Cardiovascular Diseases
      • Musculoskeletal
      • CNS
      • Infections
      • Ophthalmic
      • Others
    • By Route of Administration Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Intravenous (IV)
      • Intramuscular (IM)
      • Subcutaneous (SC)
      • Others
    • By Manufacturing Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • In-House
      • Outsource
    • By Distribution Channel Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Presentation Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Ampules
      • Vials
      • Prefilled Syringes
      • Lyophilized Products
      • Dry Powder Injectable
      • Pen Injectors
    • By End User Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Human
      • Veterinary
    • Country Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Generic Injectables Market – Opportunity Analysis Index, By Molecule Type, Drug Type, By Indication, By Route of Administration, Manufacturing Type, By Distribution Channel, By Presentation Type, By End User, and Country, 2019 – 2023
    • Asia-Pacific Generic Injectables Market Dynamics – Trends
  5. Latin America Generic Injectables Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
    • Molecule Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Large Molecule
      • Small Molecule
    • Drug Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Monoclonal Antibodies
      • Peptide Hormones
      • Immunoglobulin
      • Cytokines
      • Blood Factors
      • Peptide Antibiotics
      • Insulin
      • Vaccines
      • Others
    • By Indication Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Cancer
      • Diabetes
      • Cardiovascular Diseases
      • Musculoskeletal
      • CNS
      • Infections
      • Ophthalmic
      • Others
    • By Route of Administration Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Intravenous (IV)
      • Intramuscular (IM)
      • Subcutaneous (SC)
      • Others
    • By Manufacturing Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • In-House
      • Outsource
    • By Distribution Channel Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Presentation Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Ampules
      • Vials
      • Prefilled Syringes
      • Lyophilized Products
      • Dry Powder Injectable
      • Pen Injectors
    • By End User Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Human
      • Veterinary
    • Country Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Latin America Generic Injectables Market – Opportunity Analysis Index, By Molecule Type, Drug Type, By Indication, By Route of Administration, Manufacturing Type, By Distribution Channel, By Presentation Type, By End User, and Country, 2019 – 2023
    • Latin America Generic Injectables Market Dynamics – Trends
  6. Middle East and Africa Generic Injectables Market Analysis, 2013 – 2018 and Forecast, 2019 – 2023 (Revenue, USD Mn)
    • Molecule Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Large Molecule
      • Small Molecule
    • Drug Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Monoclonal Antibodies
      • Peptide Hormones
      • Immunoglobulin
      • Cytokines
      • Blood Factors
      • Peptide Antibiotics
      • Insulin
      • Vaccines
      • Others
    • By Indication Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Cancer
      • Diabetes
      • Cardiovascular Diseases
      • Musculoskeletal
      • CNS
      • Infections
      • Ophthalmic
      • Others
    • By Route of Administration Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Intravenous (IV)
      • Intramuscular (IM)
      • Subcutaneous (SC)
      • Others
    • By Manufacturing Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • In-House
      • Outsource
    • By Distribution Channel Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Presentation Type Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Ampules
      • Vials
      • Prefilled Syringes
      • Lyophilized Products
      • Dry Powder Injectable
      • Pen Injectors
    • By End User Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Human
      • Veterinary
    • Country Analysis 2013 – 2018 and Forecast 2019 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Generic Injectables Market – Opportunity Analysis Index, By Molecule Type, Drug Type, By Indication, By Route of Administration, Manufacturing Type, By Distribution Channel, By Presentation Type, By End User, and Country, 2019 – 2023
    • MEA Generic Injectables Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Novartis
      • AbbVie Inc.
      • Amgen, Inc.
      • AstraZeneca Plc
      • Baxter International Inc.
      • Gilead Sciences, Inc.
      • GlaxoSmithKline plc.
      • Johnson & Johnson
      • Merck & Co., Inc.
      • Novo Nordisk
      • Pfizer Inc
      • Hoffmann-La Roche Ltd
      • Sanofi SA
  1. Research Methodology
  2. Key Assumptions and Acronyms
$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials